Comparison of the Effectiveness of Therapeutic Ultrasound and Phonophoresis in Chronic Low Back Pain
Launched by KTO KARATAY UNIVERSITY · Apr 28, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different treatments for chronic low back pain: therapeutic ultrasound and phonophoresis. The goal is to find out which method is more effective at reducing pain, improving movement, and enhancing overall physical function in patients aged 18 to 30 who have experienced low back pain for more than three months. Participants will be randomly assigned to one of three groups—one receiving therapeutic ultrasound, another receiving phonophoresis, and a third group that will receive a placebo treatment that mimics ultrasound but doesn’t actually provide therapy.
To be eligible for this study, individuals must have a pain level of more than 5 on a scale of 0 to 10. However, those who have had back surgery are not able to participate. Throughout the study, participants will also receive additional treatments like electrical nerve stimulation, infrared therapy, and exercises for the lower back. The findings from this trial could help shape future treatments for chronic low back pain, which is increasingly common worldwide.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with low back pain for more than 3 months and pain intensity more than 5 according to VAS will be included in the study
- Exclusion Criteria:
- • patients who have undergone surgical operations
About Kto Karatay University
KTO Karatay University, a leading institution in Turkey dedicated to advancing healthcare education and research, actively sponsors clinical trials to enhance medical knowledge and improve patient outcomes. With a strong emphasis on innovation and ethical practices, the university collaborates with healthcare professionals and researchers to conduct rigorous clinical studies. Through these trials, KTO Karatay University aims to contribute valuable insights into various medical fields, fostering the development of effective therapies and treatment protocols that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported